Brief: Amarin Corporation PLC Vascepa Approved To Reduce Cardiovascular Risk In Kingdom Of Saudi Arabia
21/06/2023 14:24
June 21 (Reuters) - Amarin Corporation PLC AMRN.O :
* AMARIN CORPORATION PLC: VASCEPA (ICOSAPENT ETHYL) APPROVED
TO
REDUCE CARDIOVASCULAR RISK IN KINGDOM OF SAUDI ARABIA
Source text for Eikon: ID:nGNX9H6NXD
Further company coverage: AMRN.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Amarin
See all newsAmarin Corporation PLC reports results for the quarter ended June 30 - Earnings Summary
Ireland's Amarin Q2 revenue falls on lower licensing payments
Amarin Corporation PLC expected to post a loss of 1 cent a share - Earnings Preview
US Supreme Court backs generic drugmaker in 'skinny label' patent case (updated)
US Supreme Court backs generic drugmaker in 'skinny label' patent case